Home › Ironwood starts IBS trial in China, but stock falls on analyst forecast
 

Keywords :   


Ironwood starts IBS trial in China, but stock falls on analyst forecast

2013-09-12 13:48:54| Biotech - Topix.net

Ironwood Pharmaceuticals Inc. has announced a late-stage trial in China seeking to get its irritable bowel syndrome drug approved there, but lost 4 percent of stock value after an analyst firm lowered his price target.

Tags: china stock trial falls

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Eastern North Pacific Tropical Weather Outlook
16.05Atlantic Tropical Weather Outlook
16.05The man who turned his dead father into a chatbot
16.05Firms leaving UK 'not a crisis' says stock market boss
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
15.05Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
More »